Document Detail

New treatments for IBS.
MedLine Citation:
PMID:  23147658     Owner:  NLM     Status:  Publisher    
IBS is a common disorder that affects approximately 5-20% of the populations of Western countries; the main symptoms are abdominal pain and erratic, altered bowel habits, often accompanied by bloating. Despite an array of available pharmacological and nonpharmacological treatments aimed at a wide variety of gastrointestinal and brain targets, many patients do not report adequate symptom relief. The effect of IBS on an individual can be enormous, and the societal and financial costs overall are high, which is indicative of an unmet need for effective IBS treatments. Intense research efforts are ongoing that range from the development of new molecules for pharmacological therapies to testing the utility of internet technology to facilitate widespread delivery of efficacious behavioural therapy. This Review discusses the latest treatments for IBS, including novel nonpharmacological and pharmacological approaches. We have included estimates of the number needed to treat and the number needed to harm for selected treatments. Emerging and potential future treatments are included, with the data supporting an optimistic view about the future of IBS therapeutics. The ability to optimize therapy by individualizing management whilst also avoiding harm remains the key to achieving the best possible outcomes with currently available therapeutics.
Magnus Halland; Nicholas J Talley
Related Documents :
24716878 - Perceiving monetary loss as due to inequity reduces behavioral and cortical responses t...
24275218 - Multivariable modeling of phenotypic risk factors for first-onset tmd: the oppera prosp...
24920918 - Australian physiotherapists and their engagement with people with chronic pain: do thei...
25128878 - Learning pain-related fear: neural mechanisms mediating rapid differential conditioning...
17575488 - The impact of acute herpes zoster pain and discomfort on functional status and quality ...
21615858 - The story of the texas pain society: formation and function of a regional pain society.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-13
Journal Detail:
Title:  Nature reviews. Gastroenterology & hepatology     Volume:  -     ISSN:  1759-5053     ISO Abbreviation:  Nat Rev Gastroenterol Hepatol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500079     Medline TA:  Nat Rev Gastroenterol Hepatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Faculty of Health, University of Newcastle, University Drive, Callaghan, NSW 2308, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Divorce and Women's Risk of Health Insurance Loss.
Next Document:  Medical therapies for hepatocellular carcinoma: a critical view of the evidence.